Process for producing erythromycin derivatives
CA 2228254 C · Owner: Kawasaki, Yasushige · Inventors: Oishi, Kazuhiro; Kawasaki, Yasushige; Miura, Yutaka
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The hydroxyl group in position 2' of erythromycin A is acetylated, the hydroxyl group in position 4" is formylated and subjected to reaction for the formation of hemiketal; subsequently, the hydroxyl group in position 11 is oxidized and the hydroxyl group in position 12 is alkylated, followed by removal of the acetyl group in position 2' and the formyl group in position 4" to yield a compound; the compound is reacted with benzyloxycarbonyl chloride under basic conditions and, thereafter the, introduced benzyloxycarbonyl group is removed and the nitrogen atom in position 3' is subsequently alkylated followed by conversion to a fumarate in a crude crystal form, which is then recrystallized …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 5, 1996 and granted October 28, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 5, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 5, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.